Metraipolis › archive › dc_b60a7e63df4a
Obinutuzumab in systemic lupus erythematosus: a real-world experience — Europe PMC PMID:41346585
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41346585
- DOI
- 10.3389/fimmu.2025.1702550
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T10:16:10.673Z
- SHA-256 of the archived text
0d5ca07c0d5d82625cbdc8dd542f0cc9d4fc838d417d11a0ecd7587e4ca3ddaf- Stable URL of this page
https://metraipolis.com/documento/dc_b60a7e63df4a
How to cite
Obinutuzumab in systemic lupus erythematosus: a real-world experience — Europe PMC PMID:41346585 — Europe PMC (en), https://europepmc.org/article/MED/41346585 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b60a7e63df4a (Metraipolis archive dc_b60a7e63df4a, sha256 0d5ca07c0d5d82625cbdc8dd542f0cc9d4fc838d417d11a0ecd7587e4ca3ddaf)
BibTeX
@misc{dcb60a7e63df4a,
title = {Obinutuzumab in systemic lupus erythematosus: a real-world experience — Europe PMC PMID:41346585},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41346585},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b60a7e63df4a; sha256 0d5ca07c0d5d82625cbdc8dd542f0cc9d4fc838d417d11a0ecd7587e4ca3ddaf},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41346585. Agents can read the archived copy with the MCP tool read_document.